文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

疫苗流程映射:认识当前应对新发疫情威胁的局限

Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats.
PubMed 文献 · Vaccine · 2019-03-22

本文总结英国疫苗网络委托开发的疫苗开发工具,用于梳理疫苗研发关键阶段并识别限速瓶颈。通过流程映射发现,主要研究瓶颈涉及病原生物学理解、合适动物模型确定及制造科学投资,尤其工艺开发;同时存在GMP生产与灌装基础设施缺口,以及转基因生物监管和监管伦理审批限制,尤其对疫情病原体需新政策举措。

要点

  • 疫苗研发主要瓶颈在病原生物学、动物模型和制造工艺开发。
  • GMP生产与灌装基础设施存在缺口,转基因监管与审批需新政策。
  • 英国疫苗网络已通过资助呼吁和开发项目着手纠正这些限制。

核心结论

  • 疫苗开发工具识别出疫苗应对新发疫情时的关键限速瓶颈,涉及研究、基础设施和监管政策多层面。

研究设计与样本

  • 本文为方法学总结,介绍英国疫苗网络委托创建的疫苗开发工具及其关键发现。

主要发现

  • 主要研究瓶颈包括理解病原生物学、确定合适动物模型和投资制造科学特别是工艺开发。
  • 基础设施缺口包括GMP生产和灌装完成环节。
  • 监管限制涉及转基因生物 regulation 以及监管与伦理审批,尤其对疫情病原体需要新政策举措。

关键数值与推荐

  • 2015年西非埃博拉疫情暴露了病原研究、基础设施或监管投资不足相关的多个瓶颈。

临床怎么用

  • 预防医学与公共卫生工作者可参考该工具梳理疫苗研发关键阶段与瓶颈,用于准备和应对新发疫情。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination remains the most successful and effective mechanism of pathogen control. However, their development and deployment in epidemic settings have been limited, and the 2015 Ebola outbreak in West Africa identified several bottlenecks linked to a lack of investment in pathogen research, infrastructure or regulation. Shortly after this outbreak, the UK Government established the UK Vaccine Network to ensure the UK is better prepared to respond to pathogens outbreaks of epidemic potential. As part of their work, the network commissioned the creation of a Vaccine Development Tool (http://www.vaccinedevelopment.org.uk/) to serve as a guide to the key stages in vaccine development. The tool also set out to capture the key, rate-limiting bottlenecks in the development of vaccines against emerging infectious disease such that corrective action could be taken, be it through research, funding, infrastructure and policy, both in the UK and internationally. The main research bottlenecks were related to understanding pathogen biology, identification of appropriate animal models and investment in the manufacturing sciences, especially into process development. Infrastructure gaps in GMP manufacturing and fill-finish were also identified and limitations in GMO regulation and regulatory and ethical approvals, especially for outbreak pathogens required new policy initiatives. The UK Vaccine Network has since begun work to correct for these limitations with a series of funding calls and development programmes. This paper seeks to summarise the Vaccine Development Tool and its key findings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Drury G, Jolliffe S, Mukhopadhyay TK, et al. Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats. Vaccine. 2019. PMID: 30910404. doi:10.1016/j.vaccine.2019.01.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。